Clinical application of plant-based formulations in the management of diabetes

View at publisher Summarise with VIRAT
Authors: Georg Hofer, Elisabeth Gruber, Markus Steiner, Katharina Eder
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

An expert once noted that the oldest pharmacy on earth is the forest floor and the evidence supporting that observation grows stronger every year [1]. This research evaluated the glycemic efficacy of four standardized plant-based formulations as adjunctive therapy in type 2 diabetes mellitus compared to metformin and placebo over 24 weeks. We conducted this randomized six-arm trial at two Austrian academic medical centers between August 2022 and February 2023, enrolling 216 adults with suboptimally controlled type 2 diabetes (HbA1c 7.5–9.5%). Participants received berberine extract (500 mg twice daily), Gymnema sylvestre extract (400 mg twice daily), cinnamon extract (1 g twice daily), fenugreek seed extract (1 g twice daily), metformin (1000 mg twice daily), or placebo alongside their existing therapy. Berberine produced the strongest glycemic improvement among plant formulations, reducing HbA1c from 8.42% to 6.91% (absolute reduction 1.51 percentage points), approaching metformin’s reduction of 1.57 points. Fenugreek ranked second with a 1.13-point HbA1c decrease. Fasting blood glucose fell by 24.3% with berberine and 28.1% with metformin, compared to just 2.1% with placebo. HOMA-IR insulin resistance indices improved by 31.4% with berberine and 27.6% with fenugreek. Cinnamon extract showed the most modest effects across parameters. All plant formulations were well tolerated with adverse event rates comparable to placebo and significantly lower than metformin's gastrointestinal side effect burden. These results support berberine and fenugreek as clinically viable adjunctive therapies for type 2 diabetes, with berberine approaching conventional pharmacotherapy in glycemic efficacy.

Fields of Study & Subjects

Natural Antidiabetic Agents Studies Berberine and alkaloids research Diabetes Treatment and Management

Publication details

Journal / source
International Journal of Pharmaceutical and Clinical Research
Volume
8
Issue
1
Pages
32–37
Publication date
1 January 2026
Language
EN